Company News: Positive announcements like successful clinical trials, FDA approvals, or strategic partnerships can drive the stock price up. Conversely, negative news such as trial failures, regulatory setbacks, or financial losses can cause it to decline.

Financial Performance: Strong revenue growth, profitability, and positive cash flow generally boost investor confidence and lead to a higher stock price. Weak financials can have the opposite effect.

Market Sentiment: Overall market conditions, including economic trends and investor risk appetite, can influence the price of TNTRQ.US. A bullish market tends to lift most stocks, while a bearish market can drag them down.

Industry Trends: Developments in the biotechnology or pharmaceutical industries, such as new drug discoveries, regulatory changes, or competitive pressures, can impact the perceived value of TNTRQ.US.

Regulatory Environment: Changes in government regulations, particularly those related to drug development, approval, and pricing, can significantly affect the company's prospects and stock price.

Competition: The presence and actions of competitors, including the development of competing drugs or the entry of new players into the market, can influence TNTRQ.US's market share and profitability, thus affecting its stock price.

Clinical Trial Results: As a clinical-stage company, TNTRQ.US stock price is heavily reliant on the outcome of its clinical trials. Positive trial data will generally increase the stock price while negative data will decrease it.